Related Experiment Video
Updated: May 7, 2025

09:15
Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
228
Establishing a robust triangulation framework to explore the relationship between hearing loss and Parkinson's
Hao Zhang1, Keying Chen1, Tongyu Gao1
1Department of Biostatistics, School of Public Health, Xuzhou Medical University, 221004, Xuzhou, Jiangsu, China.
NPJ Parkinson'S Disease
|January 3, 2025
Summary
Hearing loss (HL) increases Parkinson
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- The association between hearing loss (HL) and Parkinson's disease (PD) is not well understood.
- Existing research suggests a potential link, but causal relationships and underlying genetic factors require further investigation.
Purpose of the Study:
- To investigate the relationship between hearing loss severity and Parkinson's disease risk.
- To explore the genetic underpinnings and potential causal links between HL and PD using multiple analytical approaches.
- To identify shared genetic loci and biological pathways connecting HL and PD.
Main Methods:
- Utilized individual-level and summary-level data from UK Biobank and large genome-wide association studies.
- Employed observational, Mendelian randomization, and genetic pleiotropy analyses.
- Performed genetic correlation and co-localization analyses to identify shared genetic influences.
Main Results:
- Increased Parkinson's disease risk was associated with greater hearing loss severity, particularly in older individuals and males.
- Hearing aid use was linked to a significant reduction in Parkinson's disease risk among males.
- While a direct causal link was not supported, genetic correlation analysis indicated a localized genetic overlap at 17q21.31.
- Identified 1545 single nucleotide polymorphisms (SNPs) and 63 genes with pleiotropic effects on both HL and PD, including novel SNPs and loci.
- These pleiotropic loci are enriched in key tissues (brain, heart, liver, pancreas) and associated with the dihydrolipoyl dehydrogenase complex pathway.
Conclusions:
- Hearing loss is associated with an increased risk of Parkinson's disease, with potential protective effects from hearing aids in males.
- Shared genetic factors contribute to the observed association, highlighting specific loci and biological pathways.
- This study provides insights into the complex interplay between hearing loss and Parkinson's disease, informing future research and potential therapeutic targets.
Related Concept Videos
Hearing
51.1K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.1K
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Neural Regulation
38.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
38.9K
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303

